Mumbai, Oct. 21 -- Bharat Parenterals announced that its subsidiary, Innoxel Lifesciences (Innoxel), has commenced commercial supply to the United States. The first product manufactured by Innoxel under a contract manufacturing (CMO) arrangement was launched in the U.S. market by its sponsor partner on 20 October 2026, the auspicious day of Vijayadashami.

Published by HT Digital Content Services with permission from Capital Market....